ESS
44
5
KLAC
45
3
LB
16
9
LUV
45
3
WFC
58
8
EXPE
83
8
IBM
53
2
DD
44
2
COF
48
3
AMG
33
-11
AMT
30
2
ORCL
49
3
HCP
54
2
EMC
30
-26
SPG
45
2
ALL
37
3
CAT
47
3
A
43
2
CHD
34
7
CMA
42
3
ESS
44
5
KLAC
45
3
LB
16
9
LUV
45
3
WFC
58
8
EXPE
83
8
IBM
53
2
DD
44
2
COF
48
3
AMG
33
-11
AMT
30
2
ORCL
49
3
HCP
54
2
EMC
30
-26
SPG
45
2
ALL
37
3
CAT
47
3
A
43
2
CHD
34
7
CMA
42
3
Financhill
Back

Zimmer Biomet Holdings 10K Form

Buy
69

ZBH
Zimmer Biomet Holdings

Last Price:
$106.00
Seasonality Move:
5.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZBH News And Ratings

See the #1 stock for the next 7 days that we like better than ZBH

ZBH Financial Statistics

Sales & Book Value

Annual Sales: $7.4B
Cash Flow: $368.6M
Price / Cash Flow: 17.53
Annual Sales: $62.00
Price / Book: 1.72

Profitability

EPS (TTM): 5.26000
Net Income (TTM): $1.1B
Gross Margin: $5.3B
Return on Equity: 8.63%
Return on Assets: 5.04%

Zimmer Biomet Holdings Earnings Forecast

Key Zimmer Biomet Holdings Financial Ratios

  • The Gross Profit Margin over the past 24 years for ZBH is 71.82%.
  • The Selling, General & Administrative Expenses for ZBH have been equal to 38.39% of Gross Profit Margin.
  • The Research & Development expenses have been 6.20% of Revenue.
  • The Interest Expense is 19.65% of Operating Income.
  • The Net Earning history of ZBH is 13.85% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Zimmer Biomet Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ZBH
CUSIP: 98956P
Website: zimmerbiomet.com

Debt

Debt-to-Equity Ratio: 0.53
Current Ratio: 1.36
Quick Ratio: 0.57

Price-to-Earnings

Trailing P/E Ratio: 21.95
Forward P/E Ratio: 12.51

ZBH Technical Analysis vs Fundamental Analysis

Buy
69
Zimmer Biomet Holdings (ZBH) is a Buy

Is Zimmer Biomet Holdings a Buy or a Sell?